Enanta Pharmaceuticals (ENTA) Return on Capital Employed (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 615.00 |
| Dec 31, 2025 | 716.00 |
| Sep 30, 2025 | 98.00 |
| Jun 30, 2025 | -97.00 |
| Mar 31, 2025 | -4.00 |
| Dec 31, 2024 | 167.00 |
| Sep 30, 2024 | -154.00 |
| Jun 30, 2024 | 164.00 |
| Mar 31, 2024 | 15.00 |
| Dec 31, 2023 | -411.00 |
| Sep 30, 2023 | 590.00 |
| Jun 30, 2023 | 345.00 |
| Mar 31, 2023 | -586.00 |
| Dec 31, 2022 | -114.00 |
| Sep 30, 2022 | -34.00 |
| Jun 30, 2022 | -145.00 |
| Mar 31, 2022 | -177.00 |
| Dec 31, 2021 | -495.00 |
| Sep 30, 2021 | -461.00 |
| Jun 30, 2021 | -331.00 |
| Mar 31, 2021 | -439.00 |
| Dec 31, 2020 | -574.00 |
| Sep 30, 2020 | -561.00 |
| Jun 30, 2020 | -543.00 |
| Mar 31, 2020 | -225.00 |
| Dec 31, 2019 | -348.00 |
| Sep 30, 2019 | -648.00 |
| Jun 30, 2019 | -464.00 |
| Mar 31, 2019 | -561.00 |
| Dec 31, 2018 | 153.00 |
| Sep 30, 2018 | -745.00 |
| Jun 30, 2018 | 875.00 |
| Mar 31, 2018 | 726.00 |
| Dec 31, 2017 | 586.00 |
| Sep 30, 2017 | 2,109.00 |
| Jun 30, 2017 | -462.00 |
| Mar 31, 2017 | -338.00 |
| Dec 31, 2016 | -1,558.00 |
| Sep 30, 2016 | -255.00 |
| Jun 30, 2016 | -126.00 |
| Mar 31, 2016 | -2,055.00 |
| Dec 31, 2015 | -1,716.00 |
| Sep 30, 2015 | 369.00 |
| Jun 30, 2015 | -2,125.00 |
| Mar 31, 2015 | 1,318.00 |
| Dec 31, 2014 | 4,474.00 |
| Sep 30, 2014 | -269.00 |
| Jun 30, 2014 | 3,369.00 |
| Mar 31, 2014 | -205.00 |
| Dec 31, 2013 | -2,445.00 |
| Sep 30, 2013 | -11.00 |